Summary - A new market study, titled “Global Q Fever Market Size, Status and Forecast 2020-2026 ” has been featured on WiseGuyReports.
Q Fever market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Q Fever market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026
The key players covered in this study
Yashica Pharmaceuticals Private Limited (India)
Merck & Co. (US)
Atox Bio (Israel)
Teva Pharmaceutical Industries (Israel)
Basilea Pharmaceutica Ltd. (Switzerland)
MELINTA THERAPEUTICS(US)
Pfizer (US)
Cipla Inc. (India)
Market segment by Type, the product can be split into
Acute Q Fever
Chronic Q Fever
Market segment by Application, split into
Hospitals & Clinics
Diagnostic Centers
Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/5617842-global-q-fever-market-size-status-and-forecast-2020-2026
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +162-825-80070 (US)
Ph: +44 203 500 2763 (UK)
Market HighlightsThe Q fever market is estimated to be valued at USD 6,249.68 thousand by 2023 and expected to grow at a CAGR of 7.83% during the forecast period.
It is a bacterial infection caused by the Coxiella burnetiid bacteria.
It might also be caused due to air contaminated by infected animals.The various symptoms associated with Q fever include high fever, sweating, cough, breathing problem and chest pain, headache, nausea, diarrhea, abdominal pain, jaundice, muscle pain, shortness of breath, and many more.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/5490Segment analysisGlobal Q fever market has been segmented on the basis of type, diagnosis, treatment, and end user.
The acute type of Q fever is a normal flu-like illness which does not last for a longer period or sometimes gets recover on its own or requires less time.
It is attributed to the increasing adoption of pets, increasing preventive treatments, and care facilities for companion animals, rising technically advanced devices, and growing awareness regarding animal-transmitted diseases.
For instance, according to the Insurance Information Institute, in 2015, the total number of pets insured reached 1.6 million, and it grew at an annual rate of 12.0% from 2014 to 2015.
Q Fever Treatment in India.
Q fever is a disease caused by infection with Coxiella burnetii, A bacterium that affects humans and other animals.
This organism is uncommon, but may be found in cattle, sheep, goats, and other domestic mammals, including cats and dogs.
and can serve as a reservoir for the bacteria.Know About More Q Fever Contact Us.
The global Q fever market is expected to exhibit a strong 7.83% CAGR over the forecast period from 2018 to 2023, according to the latest research report from Market Research Future (MRFR).
The global Q fever market is thoroughly analyzed in the report in order to provide readers with a complete overview of the market’s major drivers and restraining factors, as well as the economic background of the market and the competitive landscape of the market.
The global Q fever market is expected to reach a valuation of more than USD 6.2 million by 2023.Q fever is a bacterial disease caused by the Coxiella burnetii bacterium.
The chronic version of Q fever is thus more feared and is the reason why considerable expenses have been made to counter the condition.Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/5490 The increasing prevalence of bacterial and other infectious diseases is likely to be the major driver for the global Q fever market over the forecast period, as this has led to considerable research expenditure on eradicating these diseases.
Contagious diseases are being researched in a number of ways around the world, with researchers looking to minimize the risk of contracting such diseases as well as ways of countering the diseases once contracted.
This is likely to be a major driver for the global Q fever market over the forecast period.The increasing population of domestic cattle and goats is also likely to be a major driver for the global Q fever market.
Mediterranean fever treatment market is also known as familial paroxysmal polyserositis is an inherited auto inflammatory disorders characterized by recurrent short episodes of fever and painful inflammation of the membranes lining the abdomen, joints, and lungs called polyserositis.
It is caused by mutations of the MEFV gene.
The mutation in this gene can eventually develop symptoms of inflammatory disease.
It is usually prevalent in people of Mediterranean origin including North African, Jewish, Arab, Armenian, Turkish, Greek or Italian ancestry.According to the statistics published by the National Organization for Rare Disorders, Inc, familial Mediterranean fever is more prevalent in the south-eastern Mediterranean area with the estimated annual prevalence of (1/200-1/1000).
Mediterranean fever treatment market is expected to grow at a substantial CAGR in the forecast period of 2019-2026.
Emergence of drugs used to treat risk associated with Mediterranean fever and high demand of disease specific novel therapies are the key factors that fueling the market growth.This Mediterranean Fever Treatment Market research report intensely analyses the potential of the market with respect to current scenario and the future prospects by considering several industry aspects of Cardinal Health industry.
